Tonix Pharmaceuticals, Inc.

Clinical trials sponsored by Tonix Pharmaceuticals, Inc., explained in plain language.

Tonix Pharmaceuticals, Inc. TNXP NASDAQ

A biopharmaceutical company developing therapies for central nervous system disorders and other conditions.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

Could a muscle relaxant lift depression? new trial underway

Symptom relief Recruiting now

This Phase 2 trial tests whether TNX-102 SL, a tablet taken under the tongue at bedtime, can improve depression symptoms in adults with moderate to severe major depressive disorder. About 360 participants will receive either the drug or a placebo nightly for 6 weeks. Researchers …

Phase 2 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 13:01 UTC

Tonix Pharmaceuticals, Inc.

Could a muscle relaxant lift depression? new trial underway